Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection, according to findings
Continue reading »
Home »
Drug helps sensory neurons regrow in the mouse central nervous system
A spinal cord injury damages the lines of communication between the body and brain, impeding the signals that drive movement
Continue reading »
Alzheimer’s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?
The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment —
Continue reading »
Research reveals drug targets for memory enhancement
Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances
Continue reading »
Study shows an increase in home drinking during COVID-19 pandemic
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual
Continue reading »
An existing drug may change tumor-associated macrophages back to cancer fighters
A form of cell communication called hedgehog signaling is vital for embryonic development in mammals. But aberrantly activated hedgehog signaling
Continue reading »
ADHD drug class leads to fewer side effects in preschool children
About 2.4 percent of preschool-age children have an attention-deficit/hyperactivity disorder (ADHD) diagnosis. For these children, behavioral interventions intended to redirect
Continue reading »
New use of old drug reduces risk of kidney cancer returning
Using an existing drug for late-stage kidney cancer at an earlier stage of the disease could reduce the risk of
Continue reading »
New anticholinergic drug keeps PTSD flashbacks and nightmares away
Post-traumatic stress disorder (PTSD) is prevalent in today’s society. Medical researchers have been seeking solutions to combat this condition and
Continue reading »
Antidiabetic drug causes double the weight loss of competitor
Patients with Type 2 diabetes who were prescribed SGLT2 inhibitors lost more weight than patients who received GLP-1 receptor agonists,
Continue reading »